DNMT3A and acute erythroid leukemia: Similarly, in human AEL samples, DNMT3A/B and/or TET2 mutations were present in some AEL patients, and the combination of TET2 and DNMT3A was reported to upregulate erythroid transcription factor KLF1 and EPOR in HSCs [31].